Cipher Pharmaceuticals

高管在Cipher Pharmaceuticals变化

Scott Langille已作为Chief Financial Officer加入公司  (新闻发布的2020七月3号).

创建提醒
跟踪 Cipher Pharmaceuticals 的高管变动

Cipher Pharmaceuticals 搜索最多的简介

• Craig Mull, Interim Chief Executive Officer
• John Mull, Director
• Arthur Deboeck, Director

单击任一高管查看其简介 >

Latest M&A news in 药店.

Tilray and Aphria have announced they will merge (posted on 12月 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on 12月 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on 11月 18, 2020).

药店 行业的其他推荐联系人

• Pfizer 企业 Albert Bourla - Chief Executive Officer and Chairman of the Board
• Roche 企业 Per-Olof Attinger - Executive Committee Secretary
• Dirk Rossmann 企业 Alice Schardt-Rossmann - Managing Director

了解更多有关药店行业的信息 >

有关 Cipher Pharmaceuticals 的最新新闻

Cipher Pharmaceuticals - Press Releases
Cipher Pharmaceuticals - Press Releases
Cipher Pharmaceuticals - Press Releases
Cipher Pharmaceuticals - Press Releases
Cipher Pharmaceuticals - Press Releases

Cipher Pharmaceuticals 在 维基百科、谷歌新闻 和 雅虎财经

Cipher Pharmaceuticals 在 LinkedIn、叽叽喳喳 和 YouTube

Cipher Pharmaceuticals 拥有 2,035 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Roche (瑞士)。

通过电子邮件联系联系该企业高管，包括 Craig Mull

致电Cipher Pharmaceuticals，电话：+1 905...

查看组织结构图

Register to receive your alert

报告错误